Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)

NCT03031782 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Psoriatic Arthritis
Enthesitis-related Arthritis

Interventions

DRUG: secukinumab
OTHER: placebo

Sponsor

Novartis Pharmaceuticals